Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss
Amylin Pharmaceuticals Inc and Eli Lilly and Co , have announced that in a head-to-head study with two other widely used diabetes medicines, the newly developed long-acting version of Byetta demonstrated superior blood sugar control and weight loss, according to it’s developers. The announcement on the new drug (which only needs to be taken once... more


